What is the future outlook for SERMs in epidemiology?
The future of SERMs in epidemiology looks promising, with ongoing research aimed at developing newer agents with improved efficacy and safety profiles. For example, newer SERMs like bazedoxifene are being studied for their potential benefits in both breast cancer and osteoporosis. Additionally, the integration of SERMs into personalized medicine approaches holds the promise of optimizing treatment outcomes based on individual risk profiles.